KS Bio Clinserve

Founded: 2019 • Age: 7 yrs
Contract research services in healthcare and biotechnology sectors.

About KS Bio Clinserve

KS Bio Clinserve is a Healthcare company founded in 2019. Contract research services in healthcare and biotechnology sectors. Its Indian entity Ks Bio Clinserve Private Limited reported revenue of β‚Ή82.8 Lakh. KS Bio Clinserve offers products and services including Clinical Research Services and Regulatory Services. Its focus areas include Biotechnology, Clinical Research, Therapeutic Services and Pharmaceuticals.

Company details

KS Bio Clinserve is identified as a Contract Research Organization that was established by professionals from the medical and pharmaceutical fields. It is committed to delivering scientific expertise across various therapeutic areas to enhance global healthcare quality. Services such as clinical research, regulatory support, data management, and pharmacovigilance are provided to improve life standards worldwide, with a focus on ethical practices. Operations are based in India, serving both domestic and international clients through specialized expertise.

Key Metrics
  • Indian entity revenue
    ₹82.8 Lakh

    FY 2025 · +281% YoY

  • Indian entity net profit
    ₹3.8 Lakh

    FY 2025 · 5% margin

  • Indian entity EBITDA
    ₹4 Lakh

    FY 2025 · 5% margin

Products & Services of KS Bio Clinserve

KS Bio Clinserve offers a comprehensive portfolio of products and services, including Clinical Research Services and Regulatory Services.

Clinical Research Services
Research Services

Clinical research services are provided to support trials and studies in therapeutic areas

Regulatory Services
Compliance Services

Regulatory services are offered to assist with compliance and affairs in the pharmaceutical sector

Board of directors of Ks Bio Clinserve Private Limited (KS Bio Clinserve)

Ks Bio Clinserve Private Limited is the primary company behind KS Bio Clinserve. The board of Ks Bio Clinserve Private Limited currently have 2 directors; the longest-serving is Naresh Chandra Kothamasu, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Naresh Chandra Kothamasu
DIN 08420696
Director12 Apr 20197 yrs 7 moKs Bio Clinserve Private Limited
Shanthi Latha Kothamasu
DIN 06566310
Director12 Apr 20197 yrs 7 moKs Bio Clinserve Private Limited

Financials of KS Bio Clinserve

Figures of Ks Bio Clinserve Private Limited, the primary company behind KS Bio Clinserve, for FY 2025. Revenue was ₹82.8 Lakh (+281% year on year). Net profit was ₹3.8 Lakh (5% margin). EBITDA was ₹4 Lakh (5% margin). Revenue has grown at a compounded annual rate of +42% over three years and +111% over five years.

  • ₹82.8 LakhRevenue · FY 2025 · +281% YoY
  • ₹3.8 LakhNet profit · 5% margin
  • ₹4 LakhEBITDA · 5% margin
  • ₹1 LakhPaid-up capital
  • +42%Revenue CAGR, 3 years
  • +111%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ks Bio Clinserve Private Limited are on its company page.

Premium access

Detailed financial statements for KS Bio Clinserve

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about KS Bio Clinserve

KS Bio Clinserve was founded in 2019.

The primary company behind KS Bio Clinserve, Ks Bio Clinserve Private Limited, reported revenue of β‚Ή82.8 Lakh for FY 2025, up 281% year on year.

KS Bio Clinserve is identified as a Contract Research Organization that was established by professionals from the medical and pharmaceutical fields. It is committed to delivering scientific expertise across various therapeutic areas to enhance global healthcare quality. Services such as clinical research, regulatory support, data management, and pharmacovigilance are provided to improve life standards worldwide, with a focus on ethical practices. Operations are based in India, serving both domestic and international clients through specialized expertise.

KS Bio Clinserve offers Clinical Research Services and Regulatory Services.

KS Bio Clinserve operates through Ks Bio Clinserve Private Limited.

The legal entities of KS Bio Clinserve currently have 2 directors, including Naresh Chandra Kothamasu, Shanthi Latha Kothamasu.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available